BioMark Diagnostics Inc
F:20B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioMark Diagnostics Inc
F:20B
|
CA |
|
F
|
FirstEnergy Corp
XMUN:FE7
|
US |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
S
|
Shrinkflex (Thailand) PCL
SET:SFT
|
TH |
|
Mapfre SA
OTC:MPFRY
|
ES |
|
International Prospect Ventures Ltd
XTSX:IZZ
|
CA |
|
V
|
Vintcom Technology PCL
SET:VCOM
|
TH |
|
F
|
Forth Smart Service PCL
SET:FSMART
|
TH |
|
R
|
Radian Group Inc
F:RAG
|
US |
|
Ko Gold Inc
OTC:KOGDF
|
CA |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
P
|
Phatra Leasing PCL
SET:PL
|
TH |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
|
B
|
Barings BDC Inc
F:TRY
|
US |
Intrinsic Value
Is 20B undervalued or overvalued?
See the intrinsic value estimate for BioMark Diagnostics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
20B looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 20B’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What BioMark Diagnostics Does
BioMark Diagnostics Inc. is a molecular diagnostics company that develops blood- and urine-based tests for cancer detection and monitoring. Its products are meant to help find signs of disease earlier, support diagnosis, and track whether cancer is returning or responding to treatment. The company’s work centers on biomarker testing, where it looks for biological signals linked to specific cancers rather than selling drugs or hospital equipment.
- Headquarters
- Canada CA
- IPO date
- Nov 3, 2014
Revenue & Expenses Breakdown
BioMark Diagnostics Inc
Earnings Waterfall
BioMark Diagnostics Inc
The intrinsic value for BioMark Diagnostics Inc (20B) under the Base Case is hidden EUR.
Compared with the current market price of 0.286 EUR, the stock appears hidden.